Martin Buess

2.0k total citations
31 papers, 1.3k citations indexed

About

Martin Buess is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Martin Buess has authored 31 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Martin Buess's work include Lung Cancer Treatments and Mutations (7 papers), Cancer Cells and Metastasis (5 papers) and Cancer Genomics and Diagnostics (5 papers). Martin Buess is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Cancer Cells and Metastasis (5 papers) and Cancer Genomics and Diagnostics (5 papers). Martin Buess collaborates with scholars based in Switzerland, United States and Austria. Martin Buess's co-authors include Christoph Rochlitz, Richard Herrmann, Michal Rajski, Robert S. Negrin, Robert Zeiser, Christopher H. Contag, Andreas Beilhack, Vu Nguyen, Rosanna Zanetti‐Dällenbach and Jeanette Baker and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Martin Buess

28 papers receiving 1.3k citations

Peers

Countries citing papers authored by Martin Buess

Since Specialization

Citations

This map shows the geographic impact of Martin Buess's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Buess with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Buess more than expected).

Fields of papers citing papers by Martin Buess

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Buess. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Buess. The network helps show where Martin Buess may publish in the future.

Co-authorship network of co-authors of Martin Buess

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Buess. A scholar is included among the top collaborators of Martin Buess based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Buess. Martin Buess is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Androgen Deprivation Therapy for Intracranial Metastasis of a Salivary Duct Carcinoma: Case Report 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Spasenija Savic, Martin Buess	0
2	Much has changed in the last decade except overall survival: A Swiss single center analysis of treatment and survival in patients with stage IV non-small cell lung cancer 2020 ·PLoS ONE ·Till Wallrabenstein, (unknown), Arnoud J. Templeton, Martin Buess	6
3	Endothelial cell-derived nidogen-1 inhibits migration of SK-BR-3 breast cancer cells 2019 ·BMC Cancer ·Daniela A. Ferraro, Francesca Patella, Sara Zanivan, Cinzia Donato, Nicola Aceto, Monica Giannotta, Elisabetta Dejana, Maren Diepenbruck, Gerhard Christofori, Martin Buess	17
4	Overcoming Resistance in a BRAF V600e–Mutant Adenocarcinoma of the Lung 2018 ·Current Oncology ·Thomas Schmid, Martin Buess	4
5	BMP2 response pattern in human lung fibroblasts predicts outcome in lung adenocarcinomas 2015 ·BMC Medical Genomics ·Michal Rajski, Annika Sääf, Martin Buess	15
6	Analysis of the EGFR Mutation Status in Head and Neck Squamous Cell Carcinoma before Treatment with Gefitinib 2013 ·Oncology Research and Treatment ·(unknown), Miklos Pless, Martin Brutsche, Claude Fischer, Christoph Rochlitz, Martin Buess	4
7	Results of concurrent radio-chemotherapy for the treatment of head and neck squamous cell carcinoma in everyday clinical practice with special reference to early mortality 2013 ·BMC Cancer ·Michael Schlumpf, Claude Fischer, (unknown), Christoph Rochlitz, Martin Buess	21
8	Global Gene Expression Analysis of the Interaction between Cancer Cells and Osteoblasts to Predict Bone Metastasis in Breast Cancer 2012 ·PLoS ONE ·Michal Rajski, (unknown), Florent Baty, Christoph Rochlitz, Martin Buess	23
9	IGF-I induced genes in stromal fibroblasts predict the clinical outcome of breast and lung cancer patients 2010 ·BMC Medicine ·Michal Rajski, Rosanna Zanetti‐Dällenbach, (unknown), Richard Herrmann, Christoph Rochlitz, Martin Buess	302
10	Gene Profiling of Clinical Routine Biopsies and Prediction of Survival in Non–Small Cell Lung Cancer 2009 ·American Journal of Respiratory and Critical Care Medicine ·Florent Baty, (unknown), Sérgio Kaiser, M. Schumacher, Miklos Pless, Lukas Bubendorf, Spasenija Savic, Estelle Marrer, Wolfgang Budach, Martin Buess, Jeanne Kehren, Michael Tamm, Martin Brutsche	37
11	Tumor-Endothelial Interaction Links the CD44+/CD24- Phenotype with Poor Prognosis in Early-Stage Breast Cancer 2009 ·Neoplasia ·Martin Buess, Michal Rajski, (unknown), Richard Herrmann, Christoph Rochlitz	51
12	B7-03: Prediction of major NSCLC tumor classes and clinical outcome by functional genomics of small bronchoscopic tumor biopsies 2007 ·Journal of Thoracic Oncology ·Florent Baty, Martin Buess, Sérgio Kaiser, (unknown), Lukas Bubendorf, M. Schumacher, Wolfgang Budach, Jeanne Kehren, Martin Brutsche	0
13	Characterization of heterotypic interaction effects in vitro to deconvolute global gene expression profiles in cancer 2007 ·Genome biology ·Martin Buess, Dimitry S.A. Nuyten, Trevor Hastie, Torsten O. Nielsen, Robert Pesich, Patrick O. Brown	79
14	Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production 2006 ·Blood ·Robert Zeiser, Vu Nguyen, Andreas Beilhack, Martin Buess, Stephan Schulz, Jeanette Baker, Christopher H. Contag, Robert S. Negrin	390
15	Prognostic and Predictive Relevance of DNAM-1, SOCS6 and CADH-7 Genes on Chromosome 18q in Colorectal Cancer 2005 ·Oncology ·(unknown), Jean‐Louis Boulay, Pierluigi Ballabeni, Martin Buess, Luigi Terracciano, U Laffer, Gabriele Mild, Richard Herrmann, Christoph Rochlitz	26
16	STRAP Is a Strong Predictive Marker of Adjuvant Chemotherapy Benefit in Colorectal Cancer 2004 ·Neoplasia ·Martin Buess, Luigi Terracciano, (unknown), Pierluigi Ballabeni, Jean‐Louis Boulay, U Laffer, U Metzger, Richard Herrmann, Christoph Rochlitz	25
17	Amplification of SKI Is a Prognostic Marker in Early Colorectal Cancer 2004 ·Neoplasia ·Martin Buess, Luigi Terracciano, (unknown), Pierluigi Ballabeni, Jean‐Louis Boulay, U Laffer, U Metzger, Richard Herrmann, Christoph Rochlitz	54
18	Cutaneous Plasmablastic Lymphoma in an HIV-Positive Male: An Unrecognized Cutaneous Manifestation 2004 ·Dermatology ·Peter Häusermann, Nina Khanna, Martin Buess, Peter Itin, Manuel Battegay, S Dirnhofer, S.A. Buechner	33
19	Obstructive jaundice caused by enteropathy-associated T-cell lymphoma in a patient with celiac sprue 2004 ·Journal of Gastroenterology ·Martin Buess, M Steuerwald, W Wegmann, Madeleine Rothen	12
20	Direct identification of differentially expressed genes by cycle sequencing and cycle labelling using the differential display PCR primers 1997 ·Nucleic Acids Research ·Martin Buess	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact